Question 23

Pregnant pharmacy staff should avoid handling finasteride without proper protection.

Finasteride is known to pose risks to fetal development, particularly in male fetuses, due to its effects on hormone regulation. Therefore, pregnant pharmacy staff should take precautions when handling this medication.

A) furosemide.

Furosemide is a loop diuretic primarily used to treat fluid retention. While it may have side effects, it is not specifically indicated to negatively impact fetal development in the same manner as finasteride, making it a safer option for pregnant personnel to handle with appropriate precautions.

B) finasteride.

Finasteride is a 5-alpha-reductase inhibitor that is contraindicated during pregnancy because it can cause birth defects, particularly affecting male sexual development. This significant risk necessitates that pregnant staff avoid handling this medication without proper protective measures.

C) fluoxetine.

Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat depression and anxiety. While there are considerations regarding its use during pregnancy, it does not have the same level of risk for fetal development as finasteride, allowing pharmacy staff to handle it with caution and under guidance.

D) famotidine.

Famotidine is an H2 receptor antagonist used for reducing stomach acid. It is generally considered safe for use during pregnancy and does not have the same teratogenic effects as finasteride, thus posing less risk for pregnant pharmacy staff.

Conclusion

Finasteride is definitively the medication that pregnant pharmacy staff should avoid handling without proper protection due to its known risks to fetal development. In contrast, the other options—furosemide, fluoxetine, and famotidine—do not carry the same level of concern, making them comparatively safer to manage. Understanding the specific risks associated with certain medications is crucial in safeguarding both maternal and fetal health.